![](/img/cover-not-exists.png)
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study
O'Brien, Christopher F., Jimenez, Roland, Hauser, Robert A., Factor, Stewart A., Burke, Joshua, Mandri, Daniel, Castro-Gayol, Julio C.Volume:
30
Language:
english
Journal:
Movement Disorders
DOI:
10.1002/mds.26330
Date:
October, 2015
File:
PDF, 645 KB
english, 2015